• Citer

Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study

par Dold, Markus;Bartova, Lucie;Kautzky, Alexander;Serretti, Alessandro;Porcelli, Stefano;Souery, Daniel ;Mendlewicz, Julien ;Montgomery, Stuart;Zohar, Joseph;Kasper, Siegfried S.F.
Référence European neuropsychopharmacology, 28, 12, page (1305-1313)
Publication Publié, 2018-12

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression – Results from a European multicenter study
Auteur:	Dold, Markus; Bartova, Lucie; Kautzky, Alexander; Serretti, Alessandro; Porcelli, Stefano; Souery, Daniel; Mendlewicz, Julien; Montgomery, Stuart; Zohar, Joseph; Kasper, Siegfried S.F.
Informations sur la publication:	European neuropsychopharmacology, 28, 12, page (1305-1313)
Statut de publication:	Publié, 2018-12
Sujet CREF:	Neurologie
	Psychiatrie
	Pharmacologie
	Physiopsychologie et psychologie biologique [psychiatrie]
Mots-clés:	Antidepressants
	Augmentation
	Lithium
	Major depressive disorder
	Second-generation antipsychotics
Note générale:	SCOPUS: ar.j
	DecretOANoAutActif
Langue:	Anglais
Identificateurs:	urn:issn:0924-977X
	info:doi/10.1016/j.euroneuro.2018.10.003
	info:pii/S0924977X18308381
	info:scp/85056355360
	info:pmid/30446357